Advantage Investment Management LLC: Q2 vs. Q3 2019 Portfolio Analysis
Ava Hoppe | 2 May, 2023
Investors always anticipate how their portfolio fared in any given period. Every quarter, public companies file their 13F reports with the SEC, revealing their latest holdings. Advantage Investment Management LLC is no exception, and comparing its Q2 and Q3 2019 holdings provides insights into their investment strategy.
Advantage Investment Management LLC's Q2 13F report showed it had a total value of $83.9 million invested in 77 different stocks, dominated by its top ten holdings. By Q3, the firm had invested a total value of $80.7 million in 79 different stocks. The top ten holdings made up 50.29% and 49.66% of the total portfolio in Q2 and Q3, respectively.
In the following paragraphs, we will examine the highlights and lowlights of Q2 and Q3 for Advantage Investment Management LLC, analyzing the trends and changes in their holdings and the rationale behind them.
Top gainers
One of the most significant changes for Advantage Investment Management LLC from Q2 to Q3 2019 was its investment in ISHARES TR; the firm increased its shares in USMV, IJR, and ITOT. In Q2, Advantage Investment Management LLC invested $6.887 million in USMV, acquiring 111,565 shares, while it invested $239,000 in ITOT, acquiring 3,586 shares. However, by Q3 2019, the firm increased its position in USMV by 5.08%, acquiring 116,596 shares. It also increased its position in ITOT by a massive 783.78%, investing $1.249 million and acquiring 18,626 shares.
Another potential standout for Advantage Investment Management LLC is its expanded holdings in VANGUARD SCOTTSDALE FDS. The firm acquired additional shares in VCSH, increasing its position by 3.92%, and invested $784,000. It also invested $251,000 in VGSH, a new addition to the firm's portfolio, acquiring 45,381 shares.
Top losers
Advantage Investment Management LLC reduced its positions in some of the ETFs in Q3 2019. One standout was VICTORY PORTFOLIOS II, which saw its position in CFO and CDC reduced by 6.8% and 7.2%, respectively. The firm invested $6.629 million in 135,590 shares of CFO in Q2 and then reduced its position by 6.8%, selling 10,308 shares in Q3. It invested $2.291 million in 50,296 shares of CDC in Q2 and reduced its position by 7.2%, selling 2,493 shares in Q3.
Another ETF significant investment for Advantage Investment Management LLC, where the firm saw a dip, was SPDR SERIES TR. The firm acquired 51,918 shares in Q2, investing $5.395 million, but later reduced its holding by 2.33%, selling 1,211 shares in Q3 2019.
New additions
Advantage Investment Management LLC added four new stocks to their portfolio in Q3 2019-SPHD, BND, SCHP, and EEMV, investing a total of $3.87 million. The position in BND is the most notable, where the firm invested $502,000, acquiring 5,941 shares.
The rationale behind purchases
IShares are known for their low costs and favorable tax implications, making them attractive to investors who want to minimize their expenses and maximize returns. In Q3, Advantage Investment Management LLC acquired additional shares in USMV, IJR, and ITOT, which are all iShares. The firm's interest in iShares could be attributed to the ETF's low costs, a factor that helps maximize returns for the investor.
Vanguard ETF's are also known for their low-cost structure, which is cost-effective in the long-term. The firm's acquisition of VCSH shares could be attributed to the ETF's excellent track record of steady dividends and wide diversification, offering plenty of investment options across different industries.
Conclusion
In conclusion, the Q2 vs. Q3 2019 investment analysis of Advantage Investment Management LLC provides insights into the firm's investment strategy. The firm has added many publicly-traded firms to its portfolio, while reducing its positions in others. The notable purchase of iShares and Vanguard ETFs could be attributed to their low-cost structure, allowing investors to maximize returns. Overall, Q3 2019 saw the firm invest in potentially valuable stocks and ETFs that could pay off nicely in the long run.
Other Posts
- Tilak Healthcare Raises €10 Million to Expand Ophthalmological Telemedicine Offering
- Springing Forward: How One Equity Partners' Latest Acquisition Unlocks New Growth Horizons
- Stonehearth Capital Management, LLC Q3 2023 vs. Q4 2023 13F Holdings Comparison
- Hedeker Wealth, LLC Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Brookmont Capital Management Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Brickley Wealth Management Q4 2022 vs. Q1 2023 13F Holdings Comparison
- Investing in Energy: How Walnut Private Equity Partners' 13F Holdings Changed in Q1 2023
- Combining Forces and Forming Futures: Carlisle's Crafty Catch of MTL Holdings
- Western Standard LLC's Q3 2022 vs. Q4 2022 13F Holdings: Changes in Healthcare and Aerospace Sectors Noticed
- Strategic Advisors LLC Q2 2023 vs. Q3 2023 13F Holdings Comparison